Vertex Pharmaceuticals Incorporated (VRTX)

203.80
1.30 0.61
NASDAQ
Prev Close 205.06
Open 205.54
Day Low/High 203.13 / 205.73
52 Wk Low/High 176.36 / 242.99
Volume 625.33K
Exchange NASDAQ
Shares Outstanding 254.25B
Market Cap 51.82B
P/E Ratio 23.27
Div & Yield N.A. (N.A)
Vertex Pharmaceuticals Is in a Long-Term Decline

Vertex Pharmaceuticals Is in a Long-Term Decline

But the worst appears to be behind them.

Insider Buying Picks Up in These Biotech Stocks

Insider Buying Picks Up in These Biotech Stocks

The beaten-down biotech sector had one of the best weeks in a year. Are these names still oversold?

Bearish Bets: 2 Nasdaq Stocks You Should Consider Shorting This Week

Bearish Bets: 2 Nasdaq Stocks You Should Consider Shorting This Week

These recently downgraded names are displaying both quantitative and technical deterioration.

2 Small Stocks to Watch as Conditions Ripen for Biotech Merger Deals

2 Small Stocks to Watch as Conditions Ripen for Biotech Merger Deals

Ardelyx Inc. and Rigel Pharmaceuticals look good as stand-alone companies but also could attract suitors.

Wait a Few Days to Trade Vertex So You Don't Get Your Face Ripped Off

Wait a Few Days to Trade Vertex So You Don't Get Your Face Ripped Off

While it's tempting to take on a long-side trade here, I don't see a good reason.

Markets Focused on Relief Package, Price Is No Longer Truth, 'Unhedged Funds'

Markets Focused on Relief Package, Price Is No Longer Truth, 'Unhedged Funds'

Let's not kid ourselves that there is any longer some kind of relationship between price and value. Or fact and truth.

Vertex Rated New Outperform at Daiwa

Vertex Rated New Outperform at Bernstein

A Healthy Dose of Vaccine and Pharmaceutical Plays

A Healthy Dose of Vaccine and Pharmaceutical Plays

6 favorite stocks and ETFs in the biotech and pharmaceutical sector, including a diversified basket of Covid-19 vaccine names.

Here's How Patient Investors Could Buy Vertex Pharmaceuticals

Here's How Patient Investors Could Buy Vertex Pharmaceuticals

The short-term charts of VRTX suggest that this stock can see further sideways to lower price action in the weeks ahead.

Vertex Pharma Appears on a Healthy Trajectory

Vertex Pharma Appears on a Healthy Trajectory

Investors should continue to hold their positions on VRTX.

Earnings in Full Swing, Workplace Evolution, Fed Day

Earnings in Full Swing, Workplace Evolution, Fed Day

There was a mild increase in trading volume at the New York Stock Exchange, but it was a rotational shift.

Jim Cramer: Oil Tanked, and We're in Uncharted Waters

Jim Cramer: Oil Tanked, and We're in Uncharted Waters

Oil isn't really worthless and Amazon isn't the only retailer that will survive, but we are in a mixed up market thanks to Covid-19.

Vertex Pharmaceuticals Could See More Gains but Weaker Momentum Is a Risk

Vertex Pharmaceuticals Could See More Gains but Weaker Momentum Is a Risk

The pace of the rally in the drugmaker's shares is slowing, which is one reason to keep an eye on its stock.

Don't Underestimate Vertex Pharmaceuticals

Don't Underestimate Vertex Pharmaceuticals

Here's how the stock might surprise Wall Street.

Vertex Pharmaceuticals: The 'Endpoint' Is a Bullish Golden Cross

Vertex Pharmaceuticals: The 'Endpoint' Is a Bullish Golden Cross

VRTX is poised for further upside price gains.

The Technical Profile of This Market Remains Positive

The Technical Profile of This Market Remains Positive

The indices are within striking distance of the July highs after moving into position for a possible strong finish to the year.

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter

Straying from these names could land you in quicksand as the 4th quarter begins.

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

Jim Cramer: 5 Sectors to Buy on This 'Turkish Contagion' Market Drop

It is all about perception, and here are strong names to pick up on market weakness.

2 Trading Opportunities in Health Care

2 Trading Opportunities in Health Care

The potential of these setups on the weekly chart is rather good.

Trying the Long Side of Vertex's Stock Again

Trying the Long Side of Vertex's Stock Again

After pharmaceutical company breaks out, charts suggest now is the time to go back in.

Cramer: 2017 Was a Year of Resurrection and Revival

Cramer: 2017 Was a Year of Resurrection and Revival

Look no further than the top 10 winners in the S&P 500 and you will see just what I mean.

Cramer: Trump Doesn't Deserve All the Credit for Stock Rally

Cramer: Trump Doesn't Deserve All the Credit for Stock Rally

Of stocks seeing the biggest gains since the presidential election, only a few owe their success to Trump.

Vertex Pharmaceuticals Could Be Headed Higher Once Again

Vertex Pharmaceuticals Could Be Headed Higher Once Again

Trade from the long side, but have a sell stop below $149 in case of a reversal.

Vertex Pharmaceuticals: Looking East, West and to the Quants

Vertex Pharmaceuticals: Looking East, West and to the Quants

Let's examine VRTX's sharp decline today.

Another Day - Another Busy Slate of Earnings

Another Day - Another Busy Slate of Earnings

Ford Motor Co. leads a list of notable earnings reports being released throughout the day on Wednesday

Closing Bell: Vertex Pharmaceuticals Up on String of Upgrades; Records for Wall Street

Closing Bell: Vertex Pharmaceuticals Up on String of Upgrades; Records for Wall Street

The Nasdaq and S&P 500 ended at records for the second day in a row.

Cramer: There Are Powerful Themes in Several Bull Markets

Cramer: There Are Powerful Themes in Several Bull Markets

It's a wonder to me how split this market really is.

Takeaways and Observations: Market Reversal

"The rally in the face of today's data (detailed by Peter Boockvar in the previous post) tells me how much machines and algos dominate trading: a mild winter goosed construction jobs service job data is so-so ISM services has just given back the ent...